Steven Schmitt1, Ann T MacIntyre2, Susan C Bleasdale3, J Trees Ritter4, Sandra B Nelson5, Elie F Berbari6, Steven D Burdette7, Angela Hewlett8, Matthew Miles9, Philip A Robinson10, Javeed Siddiqui11, Robin Trotman12, Lawrence Martinelli13, Gary Zeitlin14, Andrés Rodriguez15, Mark W Smith16, Daniel P McQuillen17. 1. Department of Infectious Diseases, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Ohio. 2. Private Practice, Miami, Florida. 3. University of Illinois at Chicago. 4. Central Coast Infectious Disease Consultants, San Luis Obispo, California. 5. Massachusetts General Hospital, Boston. 6. Mayo Clinic, Rochester, Minnesota. 7. Wright State University, Dayton, Ohio. 8. University of Nebraska Medical Center, Omaha. 9. Redding Critical Care Medical Group, California. 10. Hoag Memorial Hospital Presbyterian, Newport Beach. 11. TeleMed2U, Roseville, California. 12. CoxHealth Infectious Diseases Specialty Clinic, Springfield, Missouri. 13. Providence St. Joseph Health, Lubbock, Texas. 14. White Plains Hospital Physician Associates, New York. 15. Infectious Diseases Society of America, Arlington, Virginia. 16. IBM Watson Health, Bethesda, Maryland. 17. Center for Infectious Diseases and Prevention, Lahey Hospital & Medical Center, Tufts University School of Medicine, Boston, Massachusetts.
Abstract
Background: Intervention by infectious diseases (ID) physicians improves outcomes for inpatients in Medicare, but patients with other insurance types could fare differently. We assessed whether ID involvement leads to better outcomes among privately insured patients under age 65 years hospitalized with common infections. Methods: We performed a retrospective analysis of administrative claims data from community hospital and postdischarge ambulatory care. Patients were privately insured individuals less than 65 years old with an acute-care stay in 2014 for selected infections, classed as having early (by day 3) or late (after day 3) ID intervention, or none. Key outcomes were mortality, cost, length of the index stay, readmission rate, mortality, and total cost of care over the first 30 days after discharge. Results: Patients managed with early ID involvement had shorter length of stay, lower spending, and lower mortality in the index stay than those patients managed without ID involvement. Relative to late, early ID involvement was associated with shorter length of stay and lower cost. Individuals with early ID intervention during hospitalization had fewer readmissions and lower healthcare payments after discharge. Relative to late, those with early ID intervention experienced lower readmission, lower spending, and lower mortality. Conclusions: Among privately insured patients less than 65 years old, treated in a hospital, early intervention with an ID physician was associated with lower mortality rate and shorter length of stay. Patients who received early ID intervention during their hospital stay were less likely to be readmitted after discharge and had lower total healthcare spending.
Background: Intervention by infectious diseases (ID) physicians improves outcomes for inpatients in Medicare, but patients with other insurance types could fare differently. We assessed whether ID involvement leads to better outcomes among privately insured patients under age 65 years hospitalized with common infections. Methods: We performed a retrospective analysis of administrative claims data from community hospital and postdischarge ambulatory care. Patients were privately insured individuals less than 65 years old with an acute-care stay in 2014 for selected infections, classed as having early (by day 3) or late (after day 3) ID intervention, or none. Key outcomes were mortality, cost, length of the index stay, readmission rate, mortality, and total cost of care over the first 30 days after discharge. Results:Patients managed with early ID involvement had shorter length of stay, lower spending, and lower mortality in the index stay than those patients managed without ID involvement. Relative to late, early ID involvement was associated with shorter length of stay and lower cost. Individuals with early ID intervention during hospitalization had fewer readmissions and lower healthcare payments after discharge. Relative to late, those with early ID intervention experienced lower readmission, lower spending, and lower mortality. Conclusions: Among privately insured patients less than 65 years old, treated in a hospital, early intervention with an ID physician was associated with lower mortality rate and shorter length of stay. Patients who received early ID intervention during their hospital stay were less likely to be readmitted after discharge and had lower total healthcare spending.
Authors: Jacqueline T Bork; Kimberly C Claeys; Emily L Heil; Mary Banoub; Surbhi Leekha; John D Sorkin; Michael Kleinberg Journal: Antimicrob Agents Chemother Date: 2020-07-22 Impact factor: 5.191
Authors: Oren Gordon; Nadine Peart Akindele; Christina Schumacher; Ann Hanlon; Patricia J Simner; Karen C Carroll; Anna C Sick-Samuels Journal: Pediatr Qual Saf Date: 2022-06-14
Authors: Cynthia T Nguyen; Gregory Olson; Mai T Pho; Alison K Lew; David Pitrak; Jina Saltzman; Aniruddha Hazra; Kenneth Pursell; Natasha N Pettit Journal: Open Forum Infect Dis Date: 2020-08-11 Impact factor: 3.835
Authors: Se Yoon Park; Bongyoung Kim; Dong Sik Jung; Sook In Jung; Won Sup Oh; Shin-Woo Kim; Kyong Ran Peck; Hyun-Ha Chang Journal: BMC Public Health Date: 2020-11-27 Impact factor: 3.295